Having trouble viewing this email? Click here

Weekly Digest of Events (4/2/2012 Update)

Dear Colleague,

Below please find the Massachusetts Life Sciences Center's weekly event

listings. New event titles since last week are in red. For the latest news visit our web

site at www.masslifesciences.com. Also, the Center is now on Twitter! See the link at

the bottom of this email to follow us on Twitter.

This week's listings include an expanded section on the upcoming BIO International

Convention in June. This section will grow as we get closer to the event. We are

happy to list any panels that have a Massachusetts connection - just send them my way

in the appropriate format for these listings.

If you are receiving this email as a forward, you can sign up to receive these emails

directly by using the "Join Our Mailing List" button at the bottom of this

message. Event sponsors are welcome to email me event information. We accept

event information up until 12:00 p.m. on Thursday to appear in the weekly listings the

following Monday.

-Angus

Angus G. McQuilken

Vice President for Communications

Massachusetts Life Sciences Center

amcquilken@masslifesciences.com

Upcoming Application Deadlines:

No application deadlines are pending, however the Center has recently announced the

opening of applications for this year's Internship Challenge, the Center's flagship

workforce development program. Students, recent college graduates and companies

that may want to participate are encouraged to learn more here.

BIO International Convention:

The 2012 BIO International Convention will be held June 18-21 in Boston. Have you

registered to attend? You can learn more at http://convention.bio.org.

There is a volunteer program for the 2012 BIO International Convention. The

program has you work as a volunteer for 2 days and then attend for 2 days. There is an

online application process - first come, first served. Apply early!

http://bit.ly/uhOEuO #bio2012. Questions? volunteer@bio.org

BioSpace will host the BIO Career Fair on Monday, June 18th in Boston at the Hynes

Convention Center. Free to job seekers. If you are interested in a recruiting booth,

please reserve early. http://www.biocareerfair.org/

Digital BIO Brochure Links 2012 Highlights Brochure: featuring suggested itineraries, sponsors, super sessions,

BIO Exhibition overview, registration info, housing, schedule at a glance, and more

2012 Breakout Sessions Supplement: featuring descriptions and times of all confirmed

sessions

2012 Partnering Supplement: featuring "How to partner successfully", map,

testimonials, and more

Massachusetts-related sessions at BIO:

Orphan Disease Forum - Specialized Marketing & Sales: A Vision for Orphan

and Targeted Therapies When: Wednesday, June 20, 8:30 am - 9:45 am

Where: Room #209 at the Boston Convention and Exhibition Center

Website: http://mybio.zerista.com/event/member/46585#speakers

Donna LaVoie will moderate a panel at the 2012 BIO International Convention titled,

"Specialized Marketing & Sales: A Vision for Orphan and Targeted

Therapies." Biotech companies have paved the way for specialized marketing

approaches for orphan diseases since the early 1990s. Some companies have

developed life-changing therapies that truly change disease states. Today,

biotech/pharma leaders have jumped in. But can all companies large and small find

the focus for these orphan diseases and put the patient first? What are the obstacles

associated with creating a specialized marketing and sales effort for orphan drugs?

Gain critical understanding of how companies are employing specialized marketing

and sales approaches that are patient-centric.

Speakers on the panel include:

Kyle Brown Founder & CEO of Innolyst

Jayne Gershokowitz, Senior Director of Patient Advocacy & Public Policy of

Amicus Therapeutics

Mark Rothera, Global President of Aegerion Pharmaceuticals

Rogerio Vivaldi, SVP and Head of Rare Disease Business Unit of Genzyme

Using Systems Biology to "Fast-Track" Development and Approval of Novel

Therapeutics and Diagnostics When: Thursday, June 21st, 2012, 10:00 am - 11:30 am.

Where: Boston Convention & Exhibition Center

Overview of Systems Biology and how its application can determine more precisely

and quickly which biomarkers are relevant to specific diseases for diagnosis or

therapeutic intervention. This approach can also determine subgroups or different

genotypes within these diseases in developing a diagnostic test that will determine

whether a patient will respond to a specific drug with minimal side effects.

Drugs can now be targeted for a specific set of patients resulting in higher efficacy. In

return, the FDA requirements for the number of patients required for the phase I-III

trials may be smaller, the cost and time for R&D will be reduced and the approval time

will be shorter.

Moderator:

1) Regina Au, MBA, MIM - Principal, Strategic Marketing Consultant at

BioMarketing Insight

Speakers:

1) David E. Hill, PhD - Research Scientist in Cancer Biology and Associate Director

of the Center for Cancer Systems Biology (CCSB) at the Dana-Farber Cancer Institute

(DFCI).

2) Glenn Miller, PhD - Vice President / Head of Personalized Medicine, Astra Zeneca

3) Steven Tregay, PhD - Founder, President, and CEO of Forma Therapeutics

4) FDA Speaker - TBD

For details on the session and speakers go to

http://biomarketinginsight.com/Events.htm

MassChallenge:

Applications for the MassChallenge 2012 competition are now being accepted! You

can learn more about how to apply here. The Massachusetts Life Sciences Center is a

co-sponsor of MassChallenge.

Featured Events:

Global Trade Summit 2012 When: Tuesday, April 3, 2012 11:00 a.m.- 5:00 p.m.

Where: Brandies international Business School

Register: http://www.brandeis.edu/global/tradesmmit

Early Registration Fee: $65 (For members of AIM, MassBio, MassMEDIC, and other

cooperating organizations until March 15).

$90 others

This one-day conference is the premier Massachusetts event for professionals seeking

to understand and succeed in global markets. This program is designed to help

companies identify and take advantage of international business opportunities. This

year the Summit will focus on opportunities in emerging markets and will give special

attention to four countries: Brazil, India, Israel, and Turkey. Life Sciences Center VP

for Industry Relations & Programs Pamela Norton will participate in a panel on doing

business in Israel.

Keynote address by Governor Deval Patrick

There will also be more than 25 speakers in 8 sessions.

Followed by a reception.

MBI Networking Event When: April 5, 2012, 5:30-7:00 PM

Where: Gateway Park, 60 Prescott St., Worcester, MA 01605

Register: ADVANCED REGISTRATION IS REQUIRED at

http://www.wpiventureforum.org/netform.html

Keynote Introductions:

Kevin O'Sullivan: President and CEO, Massachusetts Biomedical Initiatives

(MBI)

Deirdre E. Sanders: Chair, WPI Venture Forum Executive Board

As winter moves behind us and summer beckons on the horizon it's time to shake off

the cold and spring into networking mode. The Worcester Polytechnic (WPI) Venture

Forum and the Massachusetts Biomedical Initiatives (MBI) will be holding our first

networking event of 2012 highlighting all that is life science. During the course of the

evening attendees will have the opportunity to connect with and learn about some of

the amazing science taking place at Gateway Park through short presentations by

researchers at the park. Attendees will also have an opportunity to tour the facility and

learn firsthand about the life science resources available in our own

backyard. Speakers for the evening include:

1. Justin Mih, Matrigen Life Technologies-Softwell: Transforming the Landscape of

Cell Structure

2. Christopher Lambert - Commercial Films: Opportunities in Surface Science

This will be an amazing evening of science, innovation, and networking. Event

registration is free and required with event sign-in beginning at 5:00 PM at Gateway

Park. Presentation and facilities tours will follow from 5:45 PM on and will be

ongoing throughout the evening. Light food and refreshments will be provided.

Networking reception brought to you by the WPI Venture Forum in partnership with

and sponsored by Gateway Park and the MBI - Life Science Innovation

Event co-sponsor - Mirick O'Connell attorneys at law.

MIT Enterprise Forum of Cambridge Presents "Robotics in Healthcare:

Solutions for the Hospital and Home" When: Wednesday, April 9, 2012 (Registration-5:30pm to 6:10pm, Program:-6:10pm-

8:00pm)

Where: MIT Stata Center, Room 32-123, 32 Vassar Street, Cambridge, MA 02139

Registration: http://www.mitforumcambridge.org/events/innovation-series-event-

robotics-in-healthcare-solutions-for-the-hospital-and-the-home/

Pricing: Forum members: $25, Non-members: $45. Students from all universities are

free with college ID. Pre-registration is encouraged.

Robotics hold the promise of addressing major healthcare issues in surgery,

diagnostics, prosthetics, physical and mental therapy, monitoring, and support. The

current challenge is for the industry to move beyond the hype cycle and into practical

applications that are used in the hospital, elder and rehabilitative care, and home

environments.

Where are advances being made to personalize care and improve the quality, access

and efficiency of healthcare through robotics? Our keynote speaker will be Colin

Angle, Chairman, CEO and Co-founder of iRobot. Angle's leadership has transformed

the MIT spin-off into a global leader of practical robots. He will share the advances

iRobot is making to develop automated home care and remote presence robots to

address the emerging global need to extend independent living for the aging

population.

The Early-Stage Life Sciences Technology Conference VIII When: Thursday, April 12, 2012, 1:00 - 7:00 PM

Where: Merck Research Laboratories, 33 Avenue Louis Pasteur, Boston, MA, 02115

Website: http://www.mattcenter.org/lsconf2012/home.html

Registration: https://quikpayasp.com/massachusetts/commerce_manager/payer.do?ord

erType=Early-Stage%20Life%20Sciences%20April%202012

The Early-Stage Life Sciences Technology Conference VIII is a showcase for platform

life sciences technologies developed at the universities, research institutions, and

hospitals of Massachusetts and for recently formed Massachusetts companies. The

Forum is an opportunity for these companies and researchers to present to an audience

of angel investors, venture capitalists and corporate investors. Companies that have

presented at the first seven Early Stage Life Sciences Conferences have raised over

$100 million in new investments.

MATTO members, academics/staff at MATTO member institutions, MassBio

members, Presenters, and Exhibitors - $95.00

Non-members - $140.00

Agenda

12:45 PM - 1:15 PM Registration and Dessert Bar

1:15 PM - 1:45 PM Welcome and Financing Panel

1:45 PM - 3:00 PM Company presentations - Session One

3:00 PM - 3:30 PM Coffee Break

3:30 PM - 5:00 PM Company presentations - Session Two

5:00 PM - 7:00 PM Networking Reception and Poster Session

Boston Biotech Business Development Conference 2012 When: April 17-18, 2012

Where: Mandarin Oriental Hotel, 776 Boylston Street, Boston

Register: http://bbbiotechconference.com/conference-agenda.php?id=10

Current co-hosts include: Rich Aldrich, Josh Boger, Tony Coles, Michelle Dipp,

Samantha Du, Doug Fambrough, Colin Goddard, Sylvie Gregoire, Tuan Ha-Ngoc,

Peter Hecht, Mark Levin, John Maraganore, Lonnie Moulder, Richard Pops, George

Scangos, Henri Termeer, and Christoph Westphal.

The Boston Biotech Business Development Conference is a networking forum for

industry professionals offering exclusive access to the key decision makers who

influence deal making and investment in the life sciences. Attendees will gain insights

from presentations and panels featuring business development decision-makers from

several of the world's leading pharmaceutical and biotechnology companies, on the

current and future outlook for licensing, M&A and other business development

activities in the life sciences sector. In between learning what it takes to get a deal

done in biotech, the Business Development Conference offers opportunities

throughout the day to network one-on-one with the industry's top deal makers - senior

executives from biotech and pharma, leaders from Wall Street and venture capitalists.

8th Stem Cell Summit When: April 19-20, 2012

Where: Hyatt Harborside Hotel, 101 Harborside Drive, Boston

Register: http://www.gtcbio.com/stemcell

The 8th Stem Cell Summit provides cutting-edge information on developments in all

areas of the stem cell industry. research including the biology, medicine, applications,

regulations, and the business of Stem Cells. This summit includes two concurrent

tracks with one focused on the biology, medicine, and applications, and the other on

the technology and business of Stem Cells. Recent developments in pre-clinical and

clinical trials of stem cell therapy, regenerative medicine and tissue engineering,

cancer stem cells, stem cell reprogramming, and regulatory policies regarding stem

cell research will be addressed. In addition, discussions will be led on business

opportunities, challenges, and potential success strategies.

Join in on the discussion and network with top executives from Sanofi-Aventis,

Athersys, Pfizer, Advanced Cell Therapeutics, Novartis, Viacyte, Baxter, Cytori

Therapeutics, Life Technologies, Fate Therapeutics, BioTime, Genzyme, Osiris,

Pleuristem, Harvard Stem Cell Institute, Massachusetts Life Sciences Center,

ReNeuron, SanBio, and many more!

BIOMEDevice Boston Conference When: April 25-26, 2012, 8:30 a.m. - 4:30 p.m.

Where: Boston Convention Center

Register: BIOMEDeviceForum.com

(Registration Fee: Call 310-996-9435 to receive 20% when you mention this

email!) Join your local peers to learn how world class innovators design and develop medical

devices - from concept to production. Medical technology professionals will find the

solutions and new ideas they need through a sequentially structured series of

interactive case studies, technology sessions, panel discussions and keynote

presentations.

Topics include:

* New innovative materials for the new or next generation devices

* Risk management in design

* Manufacturability and design transfer

* Innovation through progressive design & engineering strategies

* And more!

Translational Medicine Symposium: The Journey to Personalized Medicine When: Wednesday, May 23, 2012, 9:30 a.m.- 4:30 p.m.

Where: UK Trade & Investment, British Consulate-General, One Broadway,

Cambridge MA 02142

Register: http://www.idbs.com/events/translational-medicine-symposium-2012/

Fee: Complimentary

The success of Personalized Medicine relies on the joint efforts of hospitals, payers,

academic medical centers, pharmaceutical and diagnostic organizations. Our latest

forum for informed debate and lively discussion will take an in-depth look at all your

major informatics and analytics issues in translational medicine and biomarker

research. Topics will include, integration of Clinical, Omics, Research and Biobank

data, translational collaborations across sites and industry groups, Next Generation

Sequencing data management and analytics challenges, and clinical decision support

with Omics data.

Keynote speaker: Dr. Susan Windham-Bannister, President and CEO,

Massachusetts Life Sciences Center

John Quackenbush, Ph.D.

Professor of Computational Biology & Bioinformatics, Dana-Farber Cancer

Institute

Xinwei She, Ph.D.

Senior Research Scientist, Biological and Translational Informatics, Merck

Hai Hu, Ph. D.

Deputy Chief Scientific Officer Sr. Director of Biomedical Informatics,

Windber Research Institute

Paul Denny-Gouldson, Ph. D.

VP of Translational Medicine, IDBS

Complimentary event, followed by a reception. For more information please email

Aneta Manningtonova: aneta@idbs.com

3rd RNAi Research & Therapeutics Conference When: May 30-31, 2012

Where: Hyatt Harborside Hotel, 101 Harborside Drive, Boston

Register: http://www.gtcbio.com/rnai

GTC is proud to present our 3rd RNAi Research & Therapeutics Conference, which

will be held May 30-31, 2012 at the Hyatt Harborside in Boston, MA. We will bring

together industry leaders from major pharmaceutical companies, cutting-edge biotech

companies as well as top researchers from academia and government to present

innovative and relevant applications of current RNAi technologies to continually

improve efficacy and meaningful data output in drug discovery and development.

Topics of discussion include:

RNAi Delivery Methods

Gene Activation and Silencing by Small RNAs

Target Discovery and Validation

Therapeutic, Diagnostics and Clinical Applications

MicroRNA and Diseases

ncRNAs, lncRNA

Sign up for the RNAi Research and Therapeutics conference today!

Boston Biotech CEO Conference 2012 When: June 11-12, 2012

Where: Mandarin Oriental Hotel, 776 Boylston Street, Boston

Register: http://bbbiotechconference.com/conference-agenda.php?id=11

(Please call reservations at the Mandarin Oriental Hotel today to book your

accommodations. Room Reservations: Telephone: +1 (617) 535 8880 or +1 (866) 526

6567)

Current co-hosts include: Rich Aldrich, Josh Boger, Tony Coles, Michelle Dipp,

Samantha Du, Doug Fambrough, Colin Goddard, Sylvie Gregoire, Tuan Ha-Ngoc,

Peter Hecht, Mark Levin, John Maraganore, Lonnie Moulder, Richard Pops, George

Scangos, Henri Termeer, and Christoph Westphal.

The Boston Biotech CEO Conference is an exclusive networking forum for industry

CEOs offering access to the key decision makers in the life sciences. Attendees will

gain insights from presentations and panels featuring CEOs from several of the world's

leading pharmaceutical and biotechnology companies, industry leaders in venture

capital, strategic consulting and private equity also participate each year. The CEO

Conference offers opportunities throughout the day to network one-on-one with the

industry's top deal makers - senior executives from biotech and pharma, leaders from

Wall Street and venture capitalists.

Save the Date: Prostate Cancer Awareness Day at the State House When: June 28, 2012, 10:00 a.m.-2:00 p.m.

Where: Great Hall, Massachusetts State House

RSVP: contact@admetech.org

Prostate Cancer Awareness Day, organized each year by the AdMeTech Foundation,

seeks to raise awareness about prostate cancer and the imprtance of screening and

early detection. The program will feature elected officials, advocates and leading

researchers.

U.S. Senator Scott Brown, Senate President Therese Murray and State Representative

Benjamin Swan are scheduled to participate. The Massachusetts Life Sciences Center

is a co-sponsor of this year's event.

Other Upcoming Events:

Science & Jazz for Heart Stem Cell Therapies When: Monday, April 2, 2012

Where: Seminar - Harvard University Biological Laboratories, 16 Divinity Ave.

Concert:- Queen's Head Pub 45 Quincy St., Memorial Hall, lower level

The Consulates General of Germany in San Francisco and Boston are very pleased to

announce a series of biomedical seminars with special emphasis on translational

medicine in cardiology--seasoned with a dash of contemporary Jazz music. The

Harvard Stem Cell Institute, The Consulate General of Germany, and the Longwood

Symphony Orchestracordially invite you to:

4:00 PM Seminar: Current advances in cardiac regenerative therapies in the U.S. and

Germany Dr. Brock Reeve, Harvard Medical School Dr. Gustav Steinhoff, University

of Rostock

6:00 PM Concert: Jazz at Heart and members of the Longwood Symphony

Orchestra featuring: Dr. Gustav Steinhoff (piano), Dr. Christina Jaschkowiak

(vocals), Dr. Len Zon, LSO (trumpet), Dr. Wolfram Goessling, LSO (trumpet)

Sponsored by the Lufthansa Patient Mobility Program

This event is free and open to the public!

Key Patent Strategies for Medical Device Companies in 2012 When: April 3, 2012, 8:00am - 10:30am

Where: Mass. Medical Society, 860 Winter St, Waltham, MA 02451

Register: http://www.massmedic.com/register/key-patent-strategies-for-medical-

device-companies-in-2012/

This program will focus on how changes enacted in the America Invents Act (patent

reform) and major court decisions affect patent portfolio management and litigation

strategies in order to maximize value your companies' medical device patents. Among

the topics to be discussed are:

Fashioning patent prosecution strategies, including amendments and

continuation applications, that provide coverage over competitive products;

Coordinating among legal, R&D, marketing and business development to

inform the drafting of patent claims;

Developing patent litigation strategies that maximize long term value of a

product line and company franchise without risking your patent portfolio.

Member Cost: $50

Nonmember Cost: $85

MDG April Forum When: April 4, 2012, 5:30-8:00 PM

Where: Foley Hoag Emerging Enterprise Center, 1000 Winter Street, North Building,

Waltham

Register: http://meg.memberclicks.net/index.php?option=com_mc&view=mc&mcid=

72&eventId=323517&utm_source=Eblast+for+March+30%2C+2012&utm_campaign

=MDG+CC+Eblasts+2012&utm_medium=email

Device development demands precise, reproducible animal models with quantifiable

metrics. They allow for examination of mechanism of action and provide assurance of

safety and insight into efficacy. As device development and innovation accelerate the

challenges and demands on models rise as well. We live in a golden age of inspiration

and development and exciting time for biomedical sciences. The proof of performance

concept, safety and efficacy of emerging technologies is best evaluated in animal

models. Though increasing sophistication in device development, animal medicine,

and model design has provided sophisticated tools but, preclinical model development

still remain a challenge. Accepted models are limited as evolving technology is

extended into multi dimensional and complex therapeutic areas. Quantification of

effect creates further needs with far greater attention paid than ever before to precise

definition of device performance. For all technologies, biological responses must be

evaluated acutely and chronically. Thus, the animal model choice will depend on the

device and the parameters that need to be evaluated.This session will review the

different scenarios for effectively using pre-clinical testing as a basis for getting

regulatory approval for clinical (human) testing. You will hear first-hand experiences

about possible approaches and changes being considered.

WEST's: More Time for You Now

When: Wednesday, April 4, 2012, 6:00-9:00 p.m.

Where: Worcester Polytechnic Institute, Gateway Park Room GP 1002, 60 Prescott

Street, Worcester, MA, 01605

Register: http://www.westorg.org/2012-04-04-more-time-for-you-now

Led by Alesia Latson, author of the book, More Time for You Now, this program

focuses on managing time so that you create work life balance and have more time for

yourself. It also trains you to be much more effective in your job.

Cost: Members- $45; Non-members- $75

Women Making a Difference in Healthcare Innovation When: Thursday, April 5, 2012, 11:45 a.m.-2:00 p.m.

Where: Sargent Hall Suffolk University, 120 Tremont Street, Boston, MA

Registration: www.suffolk.edu/execevents

Panel: Karen Boudreau, MD, FAAFP, SVP, Institute for Healthcare Improvement;

Emily D. Brower, Executive Director, Accountable Care Programs, Atrius Health;

Anne Lang, JD (Suffolk '79), VP of HR and Legal Services, Winchester

Hospital; Somava Stout, MD, VP for Patient-Centered Medical Home Development,

Cambridge Health Alliance

Moderator: Anne Marie Conway, RN (MHA '00), Lecturer of Healthcare

Administration, Suffolk University

Cost: $50 ($25 for Suffolk alumni, faculty, and students). Lunch included.

Is Your Future in Biotech? - Information Session for the Biomedical Laboratory

and Clinical Sciences (BLCS) program When: Thursday, April 5th, 4:00 p.m. - 5:00 p.m.

Where: Boston University Medical Campus, 801 Albany Street, Room 105, Boston

Register: To register, visit www.bu.edu/info

Boston is one of the world's preeminent biomedical centers. Today's rapid pace of innovation

and high demand for qualified professionals present a broad range of opportunities for those

with the right training. That's why it is so critical to learn from the best in the field. Boston

University's Metropolitan College and School of Medicine collaborate in offering the Bachelor

of Science in Biomedical Laboratory & Clinical Sciences-an outstanding academic program

that will prepare you for a rewarding career in biotech.

Study at a top university medical campus, in a biotech hub.

Practice skills sought by innovative companies and start-ups.

Benefit from flexible part- and full-time options to suit your schedule.

For those who already have a foundation in biology, chemistry, and math and who

wish to earn a professional credential, BU's Metropolitan College also offers

certificates in Biotechnology and in Clinical Research.

MedTech Ignite Networking Night When: Thursday, April 5, 2012, 5:00-7:00 p.m.

Where: M2D2 Innovation Hub, 600 Suffolk Street, Lowell

RSVP: Stamp@massmedic.com

MassMEDIC's MedTech IGNITE program will host an evening networking session

for start-up medical device entrepreneurs, advisors, mentors, and board members.

Refreshments and appetizers from 5pm-7pm.

Identifying the right advisory level expertise and uncovering the most innovative

medtech startups is often a daunting challenge. Come network with us and connect

with other experts!

With pointers from:

Mike Travis, principal at Travis & Company, where he was named by BusinessWeek

as one of "The World's Most Influential Headhunters."

MIT Enterprise Forum of Cambridge Presents "Robotics in Healthcare:

Solutions for the Hospital and Home" When: Wednesday, April 9, 2012 (Registration-5:30pm to 6:10pm, Program:-6:10pm-

8:00pm)

Where: MIT Stata Center, Room 32-123, 32 Vassar Street, Cambridge, MA 02139

Pricing: Forum members: $25, Non-members: $45. Students from all universities are

free with college ID. Pre-registration is encouraged at

http://www.mitforumcambridge.org/events/innovation-series-event-robotics-in-

healthcare-solutions-for-the-hospital-and-the-home/

Keynote Speaker: Colin Angle, CEO and Chairman, iRobot

Robotics hold the promise of addressing major healthcare issues in surgery,

diagnostics, prosthetics, physical and mental therapy, monitoring, and support. The

current challenge is for the industry to move beyond the hype cycle and into practical

applications that are used in the hospital, elder and rehabilitative care, and home

environments.

Register

Where are advances being made to personalize care and improve the quality, access

and efficiency of healthcare through robotics? Our keynote speaker will be Colin

Angle, Chairman, CEO and Co-founder of iRobot. Angle's leadership has transformed

the MIT spin-off into a global leader of practical robots. He will share the advances

iRobot is making to develop automated home care and remote presence robots to

address the emerging global need to extend independent living for the aging

population.

WPI - Manufacturing's Evolving Landscape When: April 10, 2012

(5:30-6:30 Networking; 6:30-8:30 Program, elevator pitch, and more networking)

Where: WPI, 100 Institute Road, Worcester, MA, Campus Center Building, 3rd floor

Register: http://www.wpiventureforum.org/registration.html

Today's manufacturing operations could be located anywhere in the world. The

decision to source manufacturing in China requires a thorough analysis of all the pros

and cons. Please join the WPI Venture Forum program on April 10 to hear keynote

speaker Christina Lampe-Önnerud, Ph.D., Founder and International Chairman,

Boston-Power Inc. examine why companies often choose China.

Free Parking: http://www.wpiventureforum.org/directions.html

MIT Enterprise Forum Healthcare & Life Science SIG Event: From Startup

Entrance to Strategic Exit: Building & Realizing Value

When: April 12, 2012 (Registration, Refreshments, and Networking 5:30-6:30PM;

Program 6:30-8:00PM)

Where: UK Trade & Investment, 7th Floor, One Broadway, Cambridge, MA 02142

Register: http://www.mitforumcambridge.org/events/healthcare-life-science-sig-event-

from-startup-entrance-to-strategic-exit-building-realizing-value/

As life science entrepreneurs build value moving from concept to strategy and then

execution, creating a pathway to a potential exit with a strategic partner is challenging,

especially since most of the entrepreneur's energy and focus is on execution and value

creation. Identifying potential corporate acquirers may seem like a simple exercise -

but developing the right awareness and working relationships leading to value-

maximizing partnerships or exits is one of the most difficult aspects of building a new

business. "From Startup Entrance to Strategic Exit" will outline key considerations

and practical tips on the funding perspectives of some strategic corporate concerns and

on the process necessary to build mutual value resulting in a successful exit.

Panelists:

Bill Gruber - President and CEO, Solace Therapeutics (current) - former President &

CEO, Interlace Therapeutics

Tom Umbel - Senior Vice President, Business Development, Hologic Corporation

Val Livada, Ph.D, MALD - Founder, Weybridge Partners and Senior Lecturer at the

Sloane School of Management

Moderator:

Larry Wittenberg, JD - Partner, Co-Chair of Technology & Life Sciences Companies

Major Practice Group, at Goodwin Procter LLP

Propel Careers: Research and Development Career Paths When: Tuesday, April 17, 2012, 5:30-8:00 p.m.

Where: MassBio Offices, Kendall Square, Cambridge

Registration: http://fils42012.eventbrite.com/

Moderator: Lauren Celano, CEO, Propel Careers

Panelists: Kenneth J. Olivier Jr., PhD, Director of Toxicology at Merrimack

Pharmaceuticals; Erin Whalen, PhD, Lab Head and Project Team Leader, Novertis

Institutes for Biomedical Research; Greg McKenzie, PhD, Senior Scientist,

Novophage

ISPE: Documentation Surrounding GMP Facilities and Processes: The Real (and

Sometimes Not-So-Real) Expectations When: April 19, 2012 (Registration and Networking Reception: 5:30 pm to 6:20 pm,

Presentation: 6:20 pm to 8:30 pm)

Where: Royal Sonesta Hotel, Cambridge, MA

Register: http://www.ispeboston.org/events/registration.htm?eventID=183

The Time, Money, Value, Quality, Safety. These variables all describe the amount of

documentation required when specifying, engineering, building, and operating GMP

facilities. This program will investigate and provide open forum discussions on what

each department involved in delivering and operating quality systems for GMP

facilities expects as the minimum documentation requirements and why. In doing so,

we will investigate the blurring lines between commissioning and qualification. We

will also look at the real value that comes from spending countless hours developing,

reviewing, and final approval cycles of the finished document and possible ways to

remediate the process. The program is designed to provide insight to all members of

the delivery and operations team including operations, manufacturing, quality,

validation, and vendors.

PANELISTS:

Chris Ames, Director Quality Assurance Validation, Genzyme .

Rob Beane, Regional Manager - Compliance, IPS (Integrated Project Services)

Mike Marino, Sr. Quality Engineer Corporate Quality Systems, Boston Scientific

Dave Mitchell, Senior QA/QC Lead, Cotter Brothers Corp

REGISTRATION FEES:

Before 04/12/2012:

Members- $50

Non Members-$95

Student Members-$5

After 04/12/2012:

Members-$60

Non Members-$115

Student Members-$10

Join ISPE now and pay the Member rate. Join within one week of this meeting, and

we'll refund you the difference between the Member and Non-Member rate! Contact

the office at (781) 647-4773 or office@ispeboston.org for more information.

The Economics of Drug Discovery

When: April 20, 2012, 5:30pm - 7:00pm

Where: Executive Leadership Center Room 412, Boston University School of

Management, 595 Commonwealth Avenue, Boston

Register: http://bit.ly/H5Z30m (Attendance is free, but pre-registration is

required)

Speaker: Dr. Jong Sung Koh (CTO of Genosco)

The pharmaceutical industry is facing unprecedented challenges to its R&D

productivity. Simply stated, without a dramatic increase in R&D productivity, today's

pharmaceutical industry cannot sustain sufficient innovation to replace the loss of

revenues arising from patent expiration of its blockbuster products. So, the key

questions are: when, how and by how much can the R&D productivity be

improved? There will be a discussion of recent strategies in drug discovery and

development to address the long-standing challenges to improving the R&D

productivity. Questions/Sponsorship opportunities: Contact admin@kabic.org.

The Effects of Healthcare Reform on Business Models, Price Structure and

Innovation - Challenges and Opportunities Ahead" When: April 26, 7:30-10:30 AM

Where: The office of Mintz Levin in Boston

Website & Registration: http://neibchealthcare.eventbrite.com/

Join the New England-Israel Business Council for an informative "Early Bird"

Networking Breakfast Meeting at the office of Mintz Levin in Boston. Feature speaker

is Richard Siegrist, Chief Innovation Officer at Press Ganey Associates and Associate

Academic Director of Masters in Health Care Management at Harvard School of

Public Health.

2012 WEST's Leadership Awards Event When: Thursday, May 3, 2012, 6:00-9:30 p.m.

Where: Hotel Marlowe, 25 Edwin H. Land Boulevard, Cambridge, MA 02141

Register: http://www.westorg.org/2012-05-03-wests-leadership-awards-

events (Registration Fee: Call 310-996-9435 to receive 20% when you mention this

email!

WEST's fifth-annual Leadership Awards Event and silent auction. This is our

opportunity to acknowledge women who have demonstrated extraordinary leadership

in science and technology.

This year's awardees: Ellen Zane, former President and CEO of Tufts Medical Center,

serves as the Chairperson of the Mass Hospital Association and a director at Parexel,

Pam Reeve, Former founder and CEO of Lightbridge, Chair of the Commonwealth

Institute board, Lead director American Towers, Leanna Caron, SVP and GM of

Sanofis Aventis's Regenerative Medicine Business, WEST Advisory board member,

Canadian and Olympic figure skating judge, Cynthia Gilbert, Technologist and patent

attorney, Founder and CEO of Hyperion Law

Cost: Members- $85; Non-members- $125. Wine, hors d'oeuvres, and a three course

meal will be served.

Activate Networks' 2012 Summit Meeting: Harness the Power of Social

Networks

When: Tuesday, May 8, 2012

Where: Charles Hotel, 1 Bennett Street, Cambridge, MA 02138

Activate Networks proudly presents Summit 2012, the world's leading conference on

leveraging your physician's social networks to drive sales results, Tue., May 8, 2012 at

the Charles Hotel, in Cambridge, Mass. Join us as real leaders discuss how to uncover

and measure real world social networks and leverage social influence for sales

targeting and identifying influential physicians. Space is limited - reserve your seat

now. For more information, visit http://www.activatenetworks.net/summit-2012

USA-India Chamber of Commerce presents its annual: US-India BioPharma &

Healthcare Summit When: Friday, May 11, 2012 at 9:30 a.m.- 7:30 p.m.

Where: President's Ballroom, Hyatt Regency, Cambridge, MA

Registration: www.usaindiachamber.org There is a $900 registration fee.

Join the USA-India Chamber of Commerce as they present its annual US-India

BioPharma & Healthcare Summit. Network with industry leaders, investors,

academicians, and policy makers. The program has the highest concentration of senior

level global BioPharma executives, R&D leaders, Academicians and VCs. Seats are

limited and registration will go up, as the seats fill.

Panel Discussions & Keynotes covering

Drug Discovery and Collaborative Research

Oncology- Science, Research Trends, Investor Perspective and Market

Opportunities

Industry-Academic Research Partnerships

Emerging Markets- Opportunities & Strategies

Funding Innovation, Cross Border Investments and M&A trends in the

BioPharma & Healthcare

Clinical Research, IP, Licensing and Regulatory Issues

R&D Models- Lessons learned for BioPharma

The 2012 ABFO National Conference

When: May 30, 2012, 1:30 PM

Where: Westin Copley Place, Boston

Register: http://www.abfointernational.org/conference.html

On May 30, 2012 at 1:30 p.m., Donna LaVoie will moderate a panel at The

Association of Bioscience Financial Officers 2012 National Conference in Boston.

The panel, titled "Top 10 Burning PR/IR Issues Facing CFOs in Transformative

Times" will address how biotechnology companies have managed through recent

change, and how CFOs should be prepared for the future in overseeing the IR/PR

function.

Participants on the panel include:

Monique Allaire, Director of Investor Relations for AVEO Pharmaceuticals

Bo Piela, Vice President of Corporate Communications for Genzyme

Maria Cantor, Vice President of Investor Relations for Ariad Pharmaceuticals

Grenoble: EuroMedtech 2012 When: May 31- June 1, 2012

Where: Grenoble, France

Registration: http://www.ebdgroup.com/emt/registration/index.php

Join us to the 4th Annual International Medtech Partnering Conference in Grenoble,

France.

You will meet executives from emerging medical technology companies, established

large medtech companies, venture capital, private equity, and institutional financial

firms, distributors and hospitals, and service related companies.

EuroMedtech™ is Europe's leading medical technology partnering conference,

providing collaboration opportunities to medtech decision makers and investors.

EuroMedtech caters to companies involved in all parts of the advanced medical

technology industry, from those serving mainline therapeutic categories such as

orthopedics and cardiovascular, through diagnostics, imaging and eHealth to those

involved in platform technologies such as biomaterials and regenerative medicine.

For more information, visit:

http://www.ebdgroup.com/emt/index.php

MassBioEd Course Schedule Announced: The MassBio Education Foundation has announced their 2012 Courses. To see

the full schedule for the winter and fall and to register, visit

https://secure.massbioed.org/courses/index.php. Course offerings include:

New Course!! Drug Development for the Non-Scientist

One Full Day, Friday May 4, 2012 from 9:00 am to 4:30 pm

NEW Course!! Managing Clinical Trials

6 week program: Thursdays from 5:30-9 pm beginning April 26, 2012 to May

31, 2012

NEW Course!! Investigations & CAPA

Full Day, Tuesday April 10, 2012, 9 am to 4:30 pm MassBio Offices

BioBasics: Biotech for the Non-Scientist, Winter 2012

Thursday & Friday February 9 & 10, 2011 from 9 am to 4:30 pm

Biotechnology Project Management, Spring 2012 Intensive

Six Weeks on Wednesday Evenings from 5:30 pm - 9:00 pm, beginning April

4th- through May 9th , 2012

Improving Biotech Presentation Skills: Spring 2012

Two-full days: Wednesdays, May 16th & June 13, 2012, 9:00 am - 5:00 pm

Leadership Training Program for Scientists, Managers, and Support Services:

Spring 2012

Two full days: Wednesdays April 4th and May 2nd, 2012, 9:00 am -5:00 pm

9th Annual Community College Program Day When: June 18, 2012 7:30 a.m.- 5:00 p.m.

Where: The Westin Waterfront Boston Hotel, 425 Summer Street, Boston, MA

02210

Registration:

http://www.regonline.com/Register/Checkin.aspx?EventID=1061901

This ninth annual BIO-associated day-long event features perspectives on

biotechnology education, training and the workforce from community college

educators and their industry partners plus a time to network with

colleagues. Organized with the help of BIO by the NBC2, Bio-Link, and NCB

W

Register online by credit card for the $150 fee per person. There will be no on

site registration. Price includes continental breakfast and delicious buffet

lunch.

MIT Professional Education Short Programs: 2012 Biotechnology /

Pharmaceutical courses for professionals These 2-5 days courses are taught on the MIT campus by MIT faculty /

researchers and experts from industry and academia

Offerings include:

Flow Chemistry: Continuous Synthesis and Purification of Pharmaceuticals

and Fine Chemicals - June 25-27, 2012

Formulation and Stabilization of Biotherapeutics - July 9-11, 2012

Controlled Release Technology: Polymeric Delivery Systems for

Pharmaceuticals, Proteins, and Other Agents - July 9-13, 2012

Nanomaterials for Biological and Pharmaceutical Technologies - July 16-20,

2012

Fermentation Technology - July 30- August 3, 2012

Downstream Processing - August 6-10, 2012

Full schedule & details: http://web.mit.edu/professional/short-

programs/courses_topic.html

TUFTS CSDD's Leadership for Drug Development Teams When: July 10-11, 2012

Where: Nine Zero Hotel, 90 Tremont Street, Boston, MA 02108

Registration: http://csdd.tufts.edu/courses/leadership_course

Who should attend: Team leaders, program managers, functional directors and

scientists form across the industry looking to build leadership skills for cross-

functional R&D.

This fast-paced two-day workshop brings together team leaders, program

managers, functional directors and scientists from across the industry to build

leadership skills for cross-functional R&D efforts. Created specifically for

pharmaceutical professionals, this highly interactive, case-based program

teaches you how to lead multi-disciplinary teams to collaborate effectively in

face of the increasingly complex challenges of life science innovation.

Early-bird registration rates are available and space is limited to 35

seats. Contact Jonathan Hsieh at jonathan.hsieh@tufts.edu or 617-636-0840

for more information.

Harvard University Office of Technology Development and Speid &

Associates Presents: Drug Development Boot Camp When: November 14-15, 2012

Where: The Harvard Club, Boston, MA

Registration: Early Bird Registration- $2,050 if paid by March 15, 2012

if paid by June 15, 2012- $2,650

if paid by October 17, 2012- $2,930

if paid after October 18, 2012- $3,430

An intense two day course for Biotech, Pharma Executives, and Harvard

University Investigators.

What Will You Learn?

Spending many years and huge sums of money developing a drug or drugs that

the market does not want, and will not pay for. Making costly mistakes

throughout the development process, which will ultimately cost the company,

one's reputation and may even lead to safety problems in those administered

the company's products. Clinical hold situations which are extremely costly.

Inability to raise funds or to find an appropriate exit.

Register Now - Space is Limited! -

www.drugstomarket.com/harvarddrugbootcamp/

Forward email

This email was sent to yolanta@bu.edu by amcquilken@masslifesciences.com | Update Profile/Email Address | Instant removal with SafeUnsubscribe™ | Privacy Policy.

Massachusetts Life Sciences Center | 1000 Winter Street, Suite 2900 | Waltham | MA | 02454